Lobbying

The Mended Hearts's latest lobbying report covers Q2 2026, at $60K. The four quarters Q3 2025–Q2 2026 total $240K. Its first report covers Q4 2022; the issues it reports most are Health Issues.

The Mended Hearts

Latest quarter
$60K
Q2 2026 · 1 reports
Last 12 months
$240K
Last 4 quarters
vs last quarter
0.0%
Q2 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

The Mended Hearts lobbying by quarter
The Mended Hearts lobbying by quarter
QuarterAmountReports
Q4 2022$01
Q1 2023$01
Q2 2023$01
Q3 2023$01
Q4 2023$01
Q1 2024$01
Q2 2024$10K1
Q3 2024$10K1
Q4 2024$30K1
Q1 2025$30K1
Q2 2025$30K1
Q3 2025$60K1
Q4 2025$60K1
Q1 2026$60K1
Q2 2026$60K1

Policy issues the reports name

  • Health issues15 reports

A report that names several issues counts once for each.

Who was lobbied

  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports

Firms it paid

Firm
Troutman Strategies$350K9 quarters
Cura Strategies$06 quarters

Former officials lobbying for it

Former position
CHRISTOPHER BAXTERResearch Assistant, Senator Bob MenendezQ2 2026
LINDSAY JORDAN AUSTINLegislative Assistant, Rep. Lynn WestmorelandQ2 2026
RYAN DIFFLEYLegislative Assistant, Rep. Robert AderholtQ2 2026
TOM TILTONLegislative Assistant, Rep. Betty SuttonQ2 2026
MICHAEL LISOWSKIAide to Rep. Joe HeckQ1 2024
SCOTT C LEEZERAide to Senator Richard DurbinQ1 2024

Lobbying reports

Filed by
07/16for Q2Troutman Strategies$60K
04/20for Q1Troutman Strategies$60K
01/15for Q4 2025Troutman Strategies$60K
25/10/16for Q3 2025Troutman Strategies$60K
25/07/17for Q2 2025Troutman Strategies$30K
25/04/10for Q1 2025Troutman Strategies$30K
25/01/21for Q4 2024Troutman Strategies$30K
24/10/17for Q3 2024Troutman Strategies$10K
24/07/19for Q2 2024Troutman Strategies$10K
24/06/13for Q2 2024Troutman StrategiesUnder $5,000
24/06/03for Q1 2024Cura StrategiesUnder $5,000
24/01/30for Q4 2023Cura StrategiesUnder $5,000
23/11/07for Q3 2023Cura StrategiesUnder $5,000
23/07/20for Q2 2023Cura StrategiesUnder $5,000
23/05/05for Q1 2023Cura StrategiesUnder $5,000
23/01/19for Q4 2022Cura StrategiesUnder $5,000